1) Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Bulter SW, Witztum JL, and Steinberg D: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesion of rabbits and man. J Clin Invest, 84: 1086-1095, 1989
2) Ylä-Herttuala S, Palinski W, Bulter SW, Picard S, Steinberg D, and Witztum JL: Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb, 14: 32-40, 1994
3) Folcik VA, Nivar-Aristy RA, Krajewski LP, and Cathcart MK: Lipoxygenase contributes to oxidation of lipids in human atherosclerotic plaques. J Clin Invest, 96 (1): 504-510, 1995
4) Kuhn H, Heydeck D, Hugou I, and Gniwotta C: In vivo action of 15-lipoxigenase in early stages of human atherogenesis. J Clin Invest, 99 (5): 888-893, 1997
5) Ehrenwald E, Chrisolm GM, and Fox PL: Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest, 93 (4): 1493-1501, 1994